Enhanced expression of glutamate decarboxylase 65 improves symptoms of rat parkinsonian models

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Gene Therapy

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302520PMID 15829994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel ex vivo angiogenesis assay based on electroporation-mediated delivery of naked plasmid DNA to skeletal muscle.

  2004cited by this paper
• Recombinant AAV‐mediated gene delivery to the central nervous system

  2004cited by this paper
• How does Parkinson's disease begin? The role of compensatory mechanisms.

  2004cited by this paper
• Development and optimization of adeno-associated virus vector transfer into the central nervous system.

  2003cited by this paper
• Effect of ipsilateral subthalamic nucleus lesioning in a rat parkinsonian model: study of behavior correlated with neuronal activity in the pedunculopontine nucleus.

  2003cited by this paper
• Effect of subthalamic lesion with kainic acid on the neuronal activities of the basal ganglia of rat parkinsonian models with 6-hydroxydopamine.

  2003cited by this paper
• Adeno-associated viral vectors.

  2003cited by this paper
• Subthalamic GAD Gene Therapy in a Parkinson's Disease Rat Model

  2002cited by this paper
• Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.

  2002cited by this paper
• Immunological Aspects of Recombinant Adeno-Associated Virus Delivery to the Mammalian Brain

  2002cited by this paper
• Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

  2001cited by this paper
• Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector.

  2001cited by this paper
• Microelectrode Recording-Guided Deep Brain Stimulation in Patients with Movement Disorders (First Trial in Korea)

  2001cited by this paper
• AAV vectors: is clinical success on the horizon?

  2000cited by this paper
• Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals.

  2000cited by this paper
• Pathophysiology of the basal ganglia in Parkinson's disease.

  2000cited by this paper
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression

  1999cited by this paper
• Recombinant adeno‐associated virus (AAV) drives constitutive production of glutamate decarboxylase in neural cell lines

  1999cited by this paper
• Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions.

  1999cited by this paper
• Purification of Recombinant Adeno-Associated Virus by Iodixanol Gradient Ultracentrifugation Allows Rapid and Reproducible Preparation of Vector Stocks for Gene Transfer in the Nervous System

  1999cited by this paper
• Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain

  1998cited by this paper
• Adeno-Associated Virus Vector-Mediated Transgene Integration into Neurons and Other Nondividing Cell Targets

  1998cited by this paper
• Gene transfer by adeno-associated virus vectors into the central nervous system.

  1997cited by this paper
• Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector.

  1996cited by this paper
• Adeno-associated Viral Vectors

  1995cited by this paper
• Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats

  1995cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Two genes encode distinct glutamate decarboxylases.

  1991cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper

• Recent developments in gene therapy for Parkinson's disease.

  2025cites this paper
• Neurosurgical gene therapy for central nervous system diseases

  2024cites this paper
• Endogenous modulation of oxidative stress and inflammation in rats fed with optimized plantain based flour and dough blends

  2023cites this paper
• Endolysosomal impairment by binding of amyloid beta or MAPT/Tau to V-ATPase and rescue via the HYAL-CD44 axis in Alzheimer disease

  2023cites this paper
• Expression, purification, and characterization of glutamate decarboxylase from human gut-originated Lactococcus garvieae MJF010

  2022cites this paper
• Quercetin and catechin assuage redox imbalance and neurochemical dysfunction in rotenone-induced neurotoxicity: A comparative in vivo experiment supported by in silico study

  2021cites this paper
• Gene delivery for Parkinson's disease

  2020cites this paper
• Pathology, Prevention and Therapeutics of Neurodegenerative Disease

  2019cites this paper
• Neuropsychological Considerations for Parkinson’s Disease Patients Being Considered for Surgical Intervention with Deep Brain Stimulation

  2019cites this paper
• Thirty years of neuroendocrinology: Technological advances pave the way for molecular discovery

  2018cites this paper
• 30 Years of Neuroendocrinology: technological advances pave the way for molecular discovery

  2018cites this paper
• Therapeutic Application of Stem Cell and Gene Therapy in Parkinson’s Disease

  2018cites this paper
• Gene Therapy for Parkinson’s Disease, An Update

  2018cites this paper
• Transplantation of GABAergic interneurons for cell-based therapy.

  2017cites this paper
• Old and new challenges in Parkinson's disease therapeutics

  2017cites this paper
• EFFECT OF MONOSODIUM GLUTAMATE ON THE SUBLINGUAL SALIVARY GLANDS OF RATS (HISTOLOGICAL AND HISTOCHEMICAL STUDY)

  2017cites this paper
• Viral Vectors and Other Modulatory Biologics

  2017cites this paper
• Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease - A Focused Review.

  2016cites this paper
• Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

  2016cites this paper
• Methods to Understand Brain Connections and Neural Function Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology

  2016cites this paper
• GAD Gene Therapy for Parkinson’s Disease

  2016cites this paper
• Gene Therapy for Parkinson’s Disease

  2016cites this paper
• Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy

  2015cites this paper
• Translational research for Parkinson׳s disease: The value of pre-clinical primate models.

  2015cites this paper
• Gene therapy using synthetic microRNA directed against GAD67 has beneficial effect on motor behaviour in 6-OHDA lesioned rats

  2014cites this paper
• Focusing brain therapeutic interventions in space and time for Parkinson's disease.

  2014cites this paper
• Advances in non-dopaminergic treatments for Parkinson's disease

  2014cites this paper
• The dopamine D2 and adenosine A2A receptors: past, present and future trends for the treatment of Parkinson's disease.

  2014cites this paper
• Antioxidant gene therapy against neuronal cell death.

  2014influential citation
• Current Trends in Treatment of Parkinson`s Disease using Gene Therapy

  2014cites this paper
• Gene Therapy for Parkinson’s Disease

  2014cites this paper
• Investigational surgical therapies

  2013cites this paper
• Gene therapy for Parkinson’s disease: state-of-the-art treatments for neurodegenerative disease

  2013cites this paper
• Gene Therapy for Parkinson's Disease

  2012cites this paper
• Parkinson's disease: gene therapies.

  2012cites this paper
• Approaches in the treatment of Parkinson's disease: A focus on stem cell-based therapies

  2012cites this paper
• Gene therapy: a viable therapeutic strategy for Parkinson’s disease?

  2011cites this paper
• An Update on Gene Therapy in Parkinson’s Disease

  2011cites this paper
• Comparison of GAD65 and 67 Immunoreactivity in the Lumbar Spinal Cord Between Young Adult and Aged Dogs

  2011cites this paper
• [Gene therapy in Parkinson disease: a promising future treatment?].

  2011cites this paper
• Development of advanced therapies based on viral vector-mediated overexpression of therapeutic molecules and knockdown of disease-related genes for Parkinson's disease.

  2011cites this paper
• Abnormal metabolic brain networks in Parkinson's disease from blackboard to bedside.

  2010cites this paper
• The effects of deep brain stimulation in neuropathic pain induced rats

  2010cites this paper
• NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson's disease.

  2010cites this paper
• Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats.

  2010cites this paper
• Gene-Based Neuromodulation

  2009cites this paper
• Effective relief of neuropathic pain by adeno-associated virus-mediated expression of a small hairpin RNA against GTP cyclohydrolase 1

  2009cites this paper
• Launching invasive, first‐in‐human trials against Parkinson's disease: Ethical considerations

  2009cites this paper
• Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2.

  2009cites this paper
• Alterations of N/OFQ and NOP receptor gene expression in the substantia nigra and caudate putamen of MPP+ and 6-OHDA lesioned rats.

  2009cites this paper
• AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease.

  2008cites this paper
• Current status of gene therapy in Asia.

  2008cites this paper
• Adeno‐associated virus‐mediated gene delivery approaches for the treatment of CNS disorders

  2008influential citation
• Potential cellular and regenerative approaches for the treatment of Parkinson’s disease

  2008cites this paper
• A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats.

  2008influential citation
• Gene therapy for Parkinson's disease: early data

  2007cites this paper
• [Gene therapy for Parkinson's disease].

  2007cites this paper
• Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

  2007cites this paper
• Subthalamic Glutamic Acid Decarboxylase Gene Therapy: Changes in Motor Function and Cortical Metabolism

  2007cites this paper
• Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease

  2007cites this paper
• Constitutive GABA expression via a recombinant adeno-associated virus consistently attenuates neuropathic pain.

  2007cites this paper
• Bibliography. Laser literature watch.

  2006cites this paper
• Analgesic effects of AAV vector expressing GAD65 in the rat dorsal root ganglia on neuropathic pain

  2006cites this paper